September 25th, 2026
Description
Open to physicians, nurses, researchers, residents, fellows, students and industry professionals, this symposium will explain ongoing clinical research available to patients at The James and surrounding communities, identify practice gaps in non-specialized care providers, introduce novel therapies into relapsed disease and provide an understanding of toxicities and tolerance, describe advances in oncology care, evaluate novel therapies in hematologic malignancies, and examine biomarkers of disease response for use in treatment decisions.
For pricing information, see pricing tab below.
Dates and Times
Start: 9/25/2026 8:00 AM
End: 9/25/2026 4:00 PM
Objectives
1. Describe evidence based therapies for the treatment of benign and malignant hematological diseases.
2. Describe the use of biomarkers in the diagnosis of hematological diseases.
3. Describe factors that may require early interventions in patients with hematological diseases.
4. List risk factors for disease severity, morbidity, and mortality.
5. Explain mechanisms of actions and risks associated with novel hematological treatments.
Pricing
| Tier | Price |
|---|---|
| NON-OSU MD, DO, PhD | $100.00 |
| OSU Faculty/Staff (Division of Hematology) | $0.00 |
| OSU Faculty/Staff (Outside Division of Hematology) | $50.00 |
| Residents/Students/Fellows | $0.00 |
| All Other Professionals | $125.00 |
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.